Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page
- Check3 days agoChange DetectedNo additions or deletions were recorded in the changes data. This indicates that the page content, as represented by the input, shows no change.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 across the page. This indicates a minor platform update and does not modify the study content or user-facing features.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.2 to v3.6.3 to reflect a minor page update.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This reflects a behind-the-scenes update to the page version without altering the displayed study details.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now shows a recruitment closure note ('No longer looking for participants'), and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Details heading formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' to reflect a consistency update.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor site build version bump.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.